BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kobeissy AA, Hashash JG, Jamali FR, Skoury AM, Haddad R, El-Samad S, Ladki R, Aswad R, Soweid AM. A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease. World J Gastroenterol 2012; 18(19): 2390-2395 [PMID: 22654431 DOI: 10.3748/wjg.v18.i19.2390]
URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2390.htm
Number Citing Articles
1
Takayoshi Suzuki, Masashi Matsushima, Aya Masui, Shingo Tsuda, Jin Imai, Jun Nakamura, Yoko Tsukune, Tetsufumi Uchida, Hiroki Yuhara, Muneki Igarashi, Jun Koike, Tetsuya Mine. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled studyWorld Journal of Gastroenterology 2015; 21(16): 5023-5031 doi: 10.3748/wjg.v21.i16.5023
2
Ying Lian Xiao, Yu Qiang Nie, Xiao Hua Hou, Peng Yan Xie, Jing Yuan Fang, Yao Zong Yuan, Li Ya Zhou, Nai Qing Zhao, Min Hu Chen. The efficacy, safety and cost-effectiveness of hydrotalciteversusesomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in ChinaJournal of Digestive Diseases 2013; 14(9): 463 doi: 10.1111/1751-2980.12069
3
Jason Abdallah, Ronnie Fass. Gastrointestinal Motility Disorders2018; : 109 doi: 10.1007/978-3-319-59352-4_10
4
Chao Zhang, Joey S. W. Kwong, Rui-Xia Yuan, Hao Chen, Chang Xu, Yi-Pin Wang, Gong-Li Yang, Jin-Zhu Yan, Le Peng, Xian-Tao Zeng, Hong Weng, Jie Luo, Yu-Ming Niu. Effectiveness and Tolerability of Different Recommended Doses of PPIs and H2RAs in GERD: Network Meta-Analysis and GRADE systemScientific Reports 2017; 7(1) doi: 10.1038/srep41021